The first step to managing brain health
is to measure it
Cambridge Cognition is a neuroscience digital health company developing products and services to better understand, detect and treat conditions affecting brain health.
Our cognitive research technologies for mobile, wearable, and online platforms accelerate the development of new treatments, improve efficiencies throughout research, and measure cognitive health and wellbeing in patients worldwide.
Our science is the recognised gold standard for assessing cognition, validated by over 30 years of data and 100,000 citations in peer-reviewed research - more than any other neuroscience company.
Our technology measures digital cognitive biomarkers, tracking improvement and decline of health in high need neurological and psychiatric conditions such as Alzheimer's, Parkinson's, depression, schizophrenia and ADHD.
Our products are used to validate the value of drug treatments, detect early signs of cognitive impairment for appropriate intervention and are a major component in understanding brain health.
Our solutions include products and services to improve:
- Research of cognitive function
- Patient finding and recruitment
- Drug development in clinical trials
- Post-marketing patient data gathering
- Study design, data analysis and patient engagement
Our customers include global pharmaceutical and biotechnology companies, contract research organisations, academic research institutions and healthcare providers in brain and mental health related disciplines.